Literature DB >> 4787532

Proceedings: The influence of urine pH on the renal excretion of practolol and propranolol.

C M Kaye, D G Robinson, P Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4787532      PMCID： PMC1776454     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  6 in total

1.  Urinary excretion kinetics of amphetamine in man.

Authors:  A H Beckett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1965-10       Impact factor: 3.765

2.  A comparison of the effects of propranolol and practolol on forced expiratory volume and resting heart rate in normal subjects.

Authors:  P Turner; J Burman; D C Hicks; N K Cherrington; J MacKinnon; T Wallet; M Woolnough
Journal:  Arch Int Pharmacodyn Ther       Date:  1971-05

3.  Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.

Authors:  G Bodem; C A Chidsey
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

4.  Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels.

Authors:  J D Fitzgerald; B Scales
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1968

5.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

6.  The buccal absorption of some -adrenoceptor blocking drugs.

Authors:  D C Hicks
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739
  6 in total
  9 in total

1.  The influence of pH on the buccal absorption and plasma and renal elimination of acebutolol.

Authors:  C M Kaye; A D Long
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  The influence of urine pH on the renal excretion of ICI 66082 in man.

Authors:  C M Kaye
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

3.  The influence of urinary pH on the elimination of mexiletine.

Authors:  M A Kiddie; C M Kaye; P Turner; T R Shaw
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

4.  Pharmacokinetics of salicylate and indomethacin in coeliac disease.

Authors:  R L Parsons; C M Kaye; K Raymond
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

5.  A study of the influence of pH on the buccal absorption and renal excretion of procainamide.

Authors:  W Meyer; C M Kaye; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Absorption of propranolol and practolol in Coeliac disease.

Authors:  R L Parsons; C M Kaye; K Raymond; J R Trounce; P Turner
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

8.  Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

Review 9.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.